Patent Assignment
Reel/Frame 064546/0453
Intellectual Property Security Agreement
Recorded: 2023-08-09
Pages: 33
Assignor
HERON THERAPEUTICS, INC.
Executed: 2023-08-09
Assignee
HERCULES CAPITAL, INC., AS AGENT
400 HAMILTON AVENUE, SUITE 310, PALO ALTO, CALIFORNIA, 94301
Covered Properties
(40)
Peg-Poly(Ortho Ester) Graft Copolymers and Pharmaceutical Compositions
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions for Delivery of Granisetron
Methods of Treating Emesis Utilizing Semi-Solid Delivery Pharmaceutical Compositions Comprising Granisetron
Process for Preparing a Semi-Solid Delivery Vehicle Comprising Granisetron
Semi-Solid Delivery Vehicle and Pharmaceutical Compositions for Delivery of Granisetron
Compositions of a Polyorthoester and an Aprotic Solvent
Compositions of a Polyorthoester and an Aprotic Solvent
Compositions of a Polyorthoester and an Aprotic Solvent
Long-Acting Polymeric Delivery Systems
Compositions of a Polyorthoester and an Organic Acid Excipient
Emulsion Formulations of Aprepitant
Emulsion Formulations of an Nk-1 Receptor Antagonist and Uses Thereof
Emulsion Formulations of Aprepitant
Long-Acting Polymeric Delivery Systems
Compositions of a Polyorthoester and an Aprotic Solvent
Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron
Long-Acting Polymeric Delivery Systems
Long-Acting Polymeric Delivery Systems
Emulsion Formulations of Aprepitant
Compositions of a Polyorthoester and an Aprotic Solvent
Long-Acting Polymeric Delivery Systems
Long-Acting Polymeric Delivery Systems
Long-Acting Polymeric Delivery Systems
Emulsion Formulations of Aprepitant
Emulsion Formulations of Aprepitant
Methods of Treating Nausea Utilizing Semi-Solid Delivery Vehicle Compositions Comprising Granisetron
Emulsion Formulations of an Nk-1 Receptor Antagonist and Uses Thereof
Long-Acting Polymeric Delivery Systems
Method of Administering Emulsion Formulations of an Nk-1 Receptor Antagonist
Application:
16/261,459 →
Publication:
US 2019/0231688
Compositions of a Polyorthoester and an Aprotic Solvent
Post-Surgical Pain Treatment
Application:
16/563,726 →
Publication:
US 2020/0078363
Emulsion Formulations of Aprepitant
Emulsion Formulations of an Nk-1 Receptor Antagonist and Uses Thereof
Long-Acting Polymeric Delivery Systems
Methods of Use of Emulsion Formulations of an Nk-1 Receptor Antagonist
Methods of Use of Emulsion Formulations of Aprepitant
Application:
17/194,114 →
Publication:
US 2021/0186981
Compositions of a Polyorthoester and an Organic Acid Excipient
Long-Acting Polymeric Delivery Systems
Application:
17/372,315 →
Publication:
US 2021/0330796
Compositions of a Polyorthoester and an Aprotic Solvent
Methods of Use of Emulsion Formulations of an Nk-1 Receptor Antagonist
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Feb 3, 2014
From: A.P. PHARMA, INC.
To: HERON THERAPEUTICS, INC.
Reel/Frame 032153/0273 →
Assignment of Assignor's Interest
May 12, 2014
From: OTTOBONI, THOMAS B.; SCHILLINGER, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 032872/0480 →
Assignment of Assignor's Interest
May 22, 2014
From: OTTOBONI, THOMAS B.; SCHILLINGER, LEE ANN LYNN; NIEMANN, JOSEPH
To: HERON THERAPEUTICS, INC.
Reel/Frame 032953/0273 →
Assignment of Assignor's Interest
Jun 9, 2014
From: OTTOBONI, THOMAS B.; SCHILLINGER, LEE ANN LYNN; NIEMANN, JOSEPH
To: HERON THERAPEUTICS, INC.
Reel/Frame 033058/0935 →
Assignment of Assignor's Interest
Apr 30, 2015
From: OTTOBONI, THOMAS B.; GIROTTI, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 035542/0050 →
Assignment of Assignor's Interest
May 18, 2015
From: OTTOBONI, THOMAS B.; GIROTTI, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 035663/0183 →
Assignment of Assignor's Interest
Apr 7, 2016
From: OTTOBONI, THOMAS B.; HAN, HAN
To: HERON THERAPEUTICS, INC.
Reel/Frame 038223/0354 →
Assignment of Assignor's Interest
May 3, 2016
From: OTTOBONI, THOMAS B.; HAN, HAN
To: HERON THERAPEUTICS, INC.
Reel/Frame 038448/0958 →
Assignment of Assignor's Interest
May 10, 2016
From: OTTOBONI, THOMAS B.; HAN, HAN
To: HERON THERAPEUTICS, INC.
Reel/Frame 038539/0148 →
Security Interest
Aug 30, 2016
From: HERON THERAPEUTICS, INC.
To: TANG CAPITAL PARTNERS, LP
Reel/Frame 039590/0239 →
Assignment of Assignor's Interest
Jan 5, 2017
From: OTTOBONI, THOMAS B.; GIROTTI, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 040867/0243 →
Assignment of Assignor's Interest
Jan 20, 2017
From: OTTOBONI, THOMAS B.; GIROTTI, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 041029/0379 →
Assignment of Assignor's Interest
Feb 2, 2018
From: OTTOBONI, THOMAS B.; SCHILLINGER, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 044813/0984 →
Change of Name
Oct 26, 2018
From: A.P. PHARMA, INC.
To: HERON THERAPEUTICS, INC.
Reel/Frame 047346/0399 →
Assignment of Assignor's Interest
Oct 26, 2018
From: NG, STEVEN Y.; SHEN, HUI-RONG; HELLER, JORGE
To: A.P. PHARMA, INC.
Reel/Frame 047331/0750 →
Release of Security Interest
Mar 25, 2021
From: TANG CAPITAL PARTNERS, LP
To: HERON THERAPEUTICS, INC.
Reel/Frame 055725/0523 →
Release of Security Interest in Patents Recorded at Reel 026177/Frame 0874
Sep 27, 2023
From: TANG CAPITAL PARTNERS, LP
To: HERON THERAPEUTICS, INC. (F/K/A A.P. PHARMA, INC.)
Reel/Frame 065045/0730 →
Assignment of Assignor's Interest
Jun 7, 2024
From: OTTOBONI, THOMAS B.; GIROTTI, LEE ANN LYNN
To: HERON THERAPEUTICS, INC.
Reel/Frame 067661/0249 →